Literature DB >> 23692940

Review of human rabies prophylaxis and treatment.

Kyle A Weant1, Stephanie N Baker.   

Abstract

Rabies is a devastating encephalitis caused by RNA viruses that use mammals as reservoirs. In the United States, most naturally acquired human cases have come from bats. The use of appropriate preexposure and postexposure prophylaxis can be nearly 100% effective. If prophylaxis is not used, or is implemented incorrectly, the patient may develop clinical rabies, which is almost universally fatal. All health care practitioners should be familiar with the appropriate evaluation of patients presenting with a possible rabies exposure and ensure that expeditious and appropriate prophylaxis is provided to help prevent the development of this lethal disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23692940     DOI: 10.1016/j.ccell.2013.02.001

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  4 in total

1.  Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial.

Authors:  Xingyu Zhou; Xiaohong Wu; Yong Cai; Shouchun Cao; Xiaoping Zhu; Qiang Lv; Huaigong Chen; Leitai Shi; Jia Li; Xinjie Wang; Yuhua Li; Rong Zhou
Journal:  Hum Vaccin Immunother       Date:  2018-12-10       Impact factor: 3.452

Review 2.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Human Rabies in China, 1960-2014: A Descriptive Epidemiological Study.

Authors:  Hang Zhou; Sirenda Vong; Kai Liu; Yu Li; Di Mu; Liping Wang; Wenwu Yin; Hongjie Yu
Journal:  PLoS Negl Trop Dis       Date:  2016-08-08

Review 4.  Saliva and viral infections.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  Periodontol 2000       Date:  2016-02       Impact factor: 7.589

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.